BEONE MEDICINES LTD. (ONC)
BeOne Medicines destaca los avances en su cartera de productos para tumores sólidos con nuevos datos presentados en ASCO 2026
BeOne Medicines destaca los avances en su cartera de productos para tumores sólidos con nuevos datos presentados en ASCO 2026
A BeOne Medicines destaca o avanço acelerado de seu pipeline de tumores sólidos com novos dados na ASCO 2026
Digital Brands Group Receives Initial Orders for $125M U.S. Program, and Expanded Partnership with GCC
BeOne Medicines evidenzia laccelerazione della sua pipeline dedicata ai tumori solidi con la presentazione di nuovi dati ad ASCO 2026
BeOne Medicines belicht versnelling in de pijplijn voor vaste tumoren met nieuwe gegevens tijdens ASCO 2026
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
LCID Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Lucid Group, Inc.
Robbins LLP Urges CVLT Stockholders Who Lost Money Investing in Commvault Systems, Inc. to Contact the Firm for Information About Leading the Class Action
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
Kuehn Law Encourages Investors of Five9, Inc. to Contact Law Firm